The apparent volume of distribution (Vd) is a pharmacokinetic parameter that relates the total amount of drug in the body to the concentration of drug measured in plasma. It is a theoretical construct, not a true physiological volume, that reflects the extent to which a drug distributes out of the plasma and into tissues. The Vd is calculated as the dose administered divided by the initial plasma concentration for an intravenous bolus, or more generally as the amount of drug in the body divided by the plasma concentration at any given time.
Relationship to Body Water Compartments
The human body contains approximately 42 L of total body water in a 70 kg individual, divided among the plasma compartment (approximately 3 L), interstitial fluid (approximately 11 L), and intracellular fluid (approximately 28 L). A drug with a Vd of 3 to 5 L is largely confined to the plasma compartment, typically because it is highly protein bound or has a high molecular weight. A drug with a Vd of approximately 15 to 20 L distributes throughout the extracellular fluid. A drug with a Vd approaching 42 L distributes throughout total body water. Values exceeding 42 L indicate extensive tissue binding or sequestration, meaning the drug concentration in tissues is much higher than in plasma.
Factors Affecting Volume of Distribution
Physicochemical properties of the drug are the primary determinants of Vd. Lipophilic drugs readily cross cell membranes and partition into adipose tissue, producing large Vd values. Thiopental, a highly lipophilic anesthetic, has a Vd of approximately 2.5 L per kg, far exceeding total body water. Hydrophilic drugs, in contrast, remain primarily in the extracellular fluid and have smaller Vd values, typically in the range of 0.15 to 0.3 L per kg.
Plasma protein binding tends to reduce Vd by keeping drug within the plasma compartment, while tissue binding increases Vd by sequestering drug in tissues. A drug that is highly bound to both plasma proteins and tissue proteins will have a Vd that reflects the balance between these competing forces. For example, digoxin is moderately bound to plasma proteins but extensively bound to Na+/K+-ATPase in cardiac and skeletal muscle, resulting in a large Vd of approximately 7 L per kg.
Age, sex, body composition, and disease states also affect Vd. Obese patients have increased adipose tissue, which can increase Vd for lipophilic drugs. Patients with edema or ascites have expanded extracellular fluid volumes, increasing the Vd for hydrophilic drugs. Neonates have higher total body water content and lower protein binding, generally resulting in larger Vd values for many drugs compared to adults.
Clinical Significance
The Vd is a critical parameter for determining loading doses. A loading dose is calculated as the desired plasma concentration multiplied by the Vd, meaning that a drug with a large Vd requires a larger loading dose to achieve a given target concentration. For example, the large Vd of hydroxychloroquine necessitates a loading regimen to achieve therapeutic concentrations within a reasonable timeframe.
The Vd also determines the elimination half-life in conjunction with clearance, according to the formula t½ = 0.693 × Vd / CL. A drug with a large Vd will have a long half-life even if clearance is normal, because the drug must be redistributed from tissue depots back into the plasma before it can be eliminated. This explains why highly lipophilic drugs that distribute extensively into fat tend to persist in the body long after discontinuation.
Examples of High and Low Volume of Distribution
Warfarin has a low Vd of approximately 0.14 L per kg, consistent with its high degree of plasma protein binding and limited tissue distribution. Ethanol has a Vd of approximately 0.6 L per kg, approximating total body water, which is why breath alcohol measurements can estimate blood alcohol concentration. Chloroquine has a very large Vd exceeding 100 L per kg due to extensive tissue accumulation, explaining its very long elimination half-life and the prolonged detection window after discontinuation.
The volume of distribution is a fundamental parameter that integrates drug properties with physiological spaces, providing insight into tissue exposure and guiding both initial dosing and expectations about drug persistence in the body.
